3E Bioventures Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6

- Investments
-
115
- Portfolio
-
73
- Exits
-
21

3E Bioventures Capital General Information
Description
Founded in 2015, 3E Bioventures Capital is a venture capital firm based in Palo Alto, California. The firm seeks to invest in companies operating in the life sciences and biomedical technology sectors.
Contact Information
Website
www.3ebiovc.com
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 228 Hamilton Avenue
- 3rd floor
- Palo Alto, CA 94301
- United States
3E Bioventures Capital Investments (115)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
KingAgroot | 08-Aug-2023 | Later Stage VC | Agricultural Chemicals | Generating Revenue | ||
0-00000000 0000000 | 19-Jul-2023 | 00000 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | |
00000000 000000000 | 23-May-2023 | 00000 00000 | 000.00 | Biotechnology | Startup | 00000 000 00.0 |
0000000 0000000000 | 27-Apr-2023 | 00000 00000 | Environmental Services (B2B) | Startup | ||
000000000 | 17-Apr-2023 | 00000 00000 | 00.00 | Monitoring Equipment | Generating Revenue | |
0000000 000 | 24-Feb-2023 | 00000 00000 | 0000 | Diagnostic Equipment | Generating Revenue | |
00000000 000000000 | 14-Feb-2023 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 3 | |
00000000 00 | 07-Feb-2023 | 00000 00000 | Biotechnology | Generating Revenue | ||
Junhemeng | 16-Jan-2023 | Early Stage VC | 000.00 | Drug Delivery | Generating Revenue | |
JUSHU | 13-Jan-2023 | Early Stage VC | 00.000 | Biotechnology | Generating Revenue |
3E Bioventures Capital Exits (21)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Cardea | 29-Apr-2023 | Merger/Acquisition | |
000 00000000000 | 02-Sep-2022 | 000 | 00000 |
0000000000 | 01-Sep-2022 | 000 | 000.00 |
000000 00000000000 | 05-Aug-2022 | 000 | 00000 |
00000000 | 01-Aug-2022 | 0000000 000000 | |
000000000 00000000 | 08-Oct-2021 | 000 | 000.00 |
00000 | 23-Jul-2021 | 000 | 00000 |
0000000000 | 01-Dec-2020 | 000000000000000000 | 00000 |
C4 Therapeutics | 02-Oct-2020 | IPO | 00000 |
Eucure Biopharma | 24-Sep-2020 | Merger/Acquisition |
3E Bioventures Capital Investments by Industry, Year, and Region
3E Bioventures Capital Team (14)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Francine Fang Ph.D | Co-Founding Partner & Managing Partner | 0 | 0 | Beijing, China | |
Qianye Liu Ph.D | Co-Founding Partner & Managing Partner | 00 | 0 | 0 | Beijing, China |
Jin Li Ph.D | Co-Founding Partner | 0 | Beijing, China | ||
Joy Yang Ph.D | Venture Partner | Beijing, China | |||
Frank Yan Ph.D | Partner | 0 | 0 | 0 | Beijing, China |
3E Bioventures Capital Co-Investors (194)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Lilly Asia Ventures | 4 | 0 |
![]() |
![]() |
|
Yijing Capital | 0 |
![]() |
![]() |
||
Co-Stone Capital | 0 |
![]() |
![]() |
||
Foothill Ventures | 0 | 0 | 0 |
![]() |
![]() |
Northern Light Venture Capital | 0 | 0 |
![]() |
![]() |